These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 31074303

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dual EGFR/HER2 inhibitors and apoptosis inducers: New benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers.
    Ghorab MM, Alsaid MS, Soliman AM.
    Bioorg Chem; 2018 Oct; 80():611-620. PubMed ID: 30041137
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers.
    Elmetwally SA, Saied KF, Eissa IH, Elkaeed EB.
    Bioorg Chem; 2019 Jul; 88():102944. PubMed ID: 31051400
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
    Maher M, Kassab AE, Zaher AF, Mahmoud Z.
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment.
    Le Y, Gan Y, Fu Y, Liu J, Li W, Zou X, Zhou Z, Wang Z, Ouyang G, Yan L.
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):555-564. PubMed ID: 31967481
    [Abstract] [Full Text] [Related]

  • 13. Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies.
    Hassan RM, Ali IH, El Kerdawy AM, Abo-Elfadl MT, Ghannam IAY.
    Bioorg Chem; 2024 Nov; 152():107728. PubMed ID: 39178704
    [Abstract] [Full Text] [Related]

  • 14. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
    AboulWafa OM, Daabees HMG, Badawi WA.
    Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
    [Abstract] [Full Text] [Related]

  • 15. Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives.
    Alkamaly OM, Altwaijry N, Sabour R, Harras MF.
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000351. PubMed ID: 33252142
    [Abstract] [Full Text] [Related]

  • 16. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, El-Gazzar MGM.
    Bioorg Med Chem Lett; 2018 May 15; 28(9):1464-1470. PubMed ID: 29628325
    [Abstract] [Full Text] [Related]

  • 17. Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and in silico studies.
    Alqahtani AS, Ghorab MM, Nasr FA, Ahmed MZ, Al-Mishari AA, Attia SM.
    J Enzyme Inhib Med Chem; 2022 Dec 15; 37(1):86-99. PubMed ID: 34894963
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells.
    Zhang Y, Wang Q, Li L, Le Y, Liu L, Yang J, Li Y, Bao G, Yan L.
    J Enzyme Inhib Med Chem; 2021 Dec 15; 36(1):1205-1216. PubMed ID: 34074193
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines.
    Aziz MW, Kamal AM, Mohamed KO, Elgendy AA.
    Bioorg Med Chem Lett; 2021 Jun 01; 41():127987. PubMed ID: 33771586
    [Abstract] [Full Text] [Related]

  • 20. Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors.
    Ghorab MM, Alsaid MS, Soliman AM, Al-Mishari AA.
    J Enzyme Inhib Med Chem; 2018 Dec 01; 33(1):67-73. PubMed ID: 29098904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.